Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

September 01, 1996; Volume 50,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Alvaro, J D

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;
  2. Animati, F

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  3. Arai, H

    1. You have access
      Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
      H Arai and J A Escobedo
      Molecular Pharmacology September 1996, 50 (3) 522-528;
  4. Arcamone, F

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;

B

  1. Bamberger, U

    1. You have access
      BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;
  2. Barak, D

    1. You have access
      Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;
  3. Barber, R

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  4. Berger, A

    1. You have access
      Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;
  5. Bigioni, M

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  6. Birnbaumer, M

    1. You have access
      A fully active nonglycosylated V2 vasopressin receptor.
      G Innamorati, H Sadeghi and M Birnbaumer
      Molecular Pharmacology September 1996, 50 (3) 467-473;
  7. Bittman, R

    1. You have access
      Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;
    2. You have access
      N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
      K Liliom, R Bittman, B Swords and G Tigyi
      Molecular Pharmacology September 1996, 50 (3) 616-623;
  8. Bouvier, M

    1. You have access
      Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
      P Chidiac, S Nouet and M Bouvier
      Molecular Pharmacology September 1996, 50 (3) 662-669;
  9. Bradford, B U

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  10. Brenner, D A

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;

C

  1. Cai, J J

    1. You have access
      Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
      H Yu, J J Cai and H C Lee
      Molecular Pharmacology September 1996, 50 (3) 549-555;
  2. Capranico, G

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  3. Cardenas, M E

    1. You have access
      Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
      D Zhu, M E Cardenas and J Heitman
      Molecular Pharmacology September 1996, 50 (3) 506-511;
  4. Carsrud, N D

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  5. Caserini, C

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  6. Chang, K J

    1. You have access
      The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors.
      L Y Li and K J Chang
      Molecular Pharmacology September 1996, 50 (3) 599-602;
  7. Chidiac, P

    1. You have access
      Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
      P Chidiac, S Nouet and M Bouvier
      Molecular Pharmacology September 1996, 50 (3) 662-669;
  8. Chieng, B

    1. You have access
      The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
      B Chieng, M Connor and M J Christie
      Molecular Pharmacology September 1996, 50 (3) 650-655;
  9. Christie, M J

    1. You have access
      The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
      B Chieng, M Connor and M J Christie
      Molecular Pharmacology September 1996, 50 (3) 650-655;
  10. Clark, R B

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  11. Connor, M

    1. You have access
      The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
      B Chieng, M Connor and M J Christie
      Molecular Pharmacology September 1996, 50 (3) 650-655;

D

  1. Day, R O

    1. You have access
      D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
      M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland
      Molecular Pharmacology September 1996, 50 (3) 501-505;
  2. De Cesare, M

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  3. De Souza, E B

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  4. Dickey, B F

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  5. Diehl, N L

    1. You have access
      Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
      N L Diehl, J C Kermode and S M Shreeve
      Molecular Pharmacology September 1996, 50 (3) 624-630;
  6. Duman, R S

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;

E

  1. Eisenhard, M

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;
  2. Eisfelder, B

    1. You have access
      Constitutive activation of a phosphoinositidase C-linked G protein in murine fibroblasts decreases agonist-stimulated Ca2+ mobilization.
      L A Lobaugh, B Eisfelder, K Gibson, G L Johnson and J W Putney
      Molecular Pharmacology September 1996, 50 (3) 493-500;
  3. Eliasson, E

    1. You have access
      Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
      E Eliasson and J G Kenna
      Molecular Pharmacology September 1996, 50 (3) 573-582;
  4. Escobedo, J A

    1. You have access
      Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
      H Arai and J A Escobedo
      Molecular Pharmacology September 1996, 50 (3) 522-528;

F

  1. Fernandez-Salguero, P

    1. You have access
      Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver.
      D Y Ryu, P E Levi, P Fernandez-Salguero, F J Gonzalez and E Hodgson
      Molecular Pharmacology September 1996, 50 (3) 443-446;
  2. Fogliano, M

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;
  3. Fukuhara, M

    1. You have access
      Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1.
      M Tohkin, K Kurose and M Fukuhara
      Molecular Pharmacology September 1996, 50 (3) 556-564;

G

  1. Gao, W

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  2. Georges, E

    1. You have access
      BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;
  3. Gibson, K

    1. You have access
      Constitutive activation of a phosphoinositidase C-linked G protein in murine fibroblasts decreases agonist-stimulated Ca2+ mobilization.
      L A Lobaugh, B Eisfelder, K Gibson, G L Johnson and J W Putney
      Molecular Pharmacology September 1996, 50 (3) 493-500;
  4. Gonzalez, F J

    1. You have access
      Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver.
      D Y Ryu, P E Levi, P Fernandez-Salguero, F J Gonzalez and E Hodgson
      Molecular Pharmacology September 1996, 50 (3) 443-446;
  5. Gribkoff, V K

    1. You have access
      Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
      J Zhong, V K Gribkoff and P B Molinoff
      Molecular Pharmacology September 1996, 50 (3) 631-638;
  6. Grigoriadis, D E

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  7. Grosfeld, H

    1. You have access
      Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;
  8. Gustafsson, J A

    1. You have access
      Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.
      J C Rowlands, I J McEwan and J A Gustafsson
      Molecular Pharmacology September 1996, 50 (3) 538-548;

H

  1. Handel, M L

    1. You have access
      D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
      M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland
      Molecular Pharmacology September 1996, 50 (3) 501-505;
  2. Heckel, A

    1. You have access
      BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;
  3. Heitman, J

    1. You have access
      Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
      D Zhu, M E Cardenas and J Heitman
      Molecular Pharmacology September 1996, 50 (3) 506-511;
  4. Hodgson, E

    1. You have access
      Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver.
      D Y Ryu, P E Levi, P Fernandez-Salguero, F J Gonzalez and E Hodgson
      Molecular Pharmacology September 1996, 50 (3) 443-446;
  5. Horisberger, J D

    1. You have access
      Mercury binding site on Na+/K(+)-ATPase: a cysteine in the first transmembrane segment.
      X Wang and J D Horisberger
      Molecular Pharmacology September 1996, 50 (3) 687-691;
  6. Hwang, S M

    1. You have access
      Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
      A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson
      Molecular Pharmacology September 1996, 50 (3) 529-537;

I

  1. Iimuro, Y

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  2. Innamorati, G

    1. You have access
      A fully active nonglycosylated V2 vasopressin receptor.
      G Innamorati, H Sadeghi and M Birnbaumer
      Molecular Pharmacology September 1996, 50 (3) 467-473;

J

  1. Jacobson, K A

    1. You have access
      Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
      Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology September 1996, 50 (3) 512-521;
  2. Jeong, J K

    1. You have access
      Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
      J K Jeong, J L Stevens, S S Lau and T J Monks
      Molecular Pharmacology September 1996, 50 (3) 592-598;
  3. Jiang, Q

    1. You have access
      Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
      Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology September 1996, 50 (3) 512-521;
  4. Johanson, K

    1. You have access
      Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
      A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson
      Molecular Pharmacology September 1996, 50 (3) 529-537;
  5. Johnson, G L

    1. You have access
      Constitutive activation of a phosphoinositidase C-linked G protein in murine fibroblasts decreases agonist-stimulated Ca2+ mobilization.
      L A Lobaugh, B Eisfelder, K Gibson, G L Johnson and J W Putney
      Molecular Pharmacology September 1996, 50 (3) 493-500;
  6. Jover, R

    1. You have access
      Role of heme in cytochrome P450 transcription and function in mice treated with lead acetate.
      R Jover, R L Lindberg and U A Meyer
      Molecular Pharmacology September 1996, 50 (3) 474-481;

K

  1. Kadiiska, M

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  2. Kapur, J

    1. You have access
      Pharmacological properties of gamma-aminobutyric acidA receptors from acutely dissociated rat dentate granule cells.
      J Kapur and R L Macdonald
      Molecular Pharmacology September 1996, 50 (3) 458-466;
  3. Kenna, J G

    1. You have access
      Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
      E Eliasson and J G Kenna
      Molecular Pharmacology September 1996, 50 (3) 573-582;
  4. Kermode, J C

    1. You have access
      Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
      N L Diehl, J C Kermode and S M Shreeve
      Molecular Pharmacology September 1996, 50 (3) 624-630;
  5. Kieffer, B

    1. You have access
      Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
      H Matthes, E P Seward, B Kieffer and R A North
      Molecular Pharmacology September 1996, 50 (3) 447-450;
  6. Kim, J

    1. You have access
      Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
      Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology September 1996, 50 (3) 512-521;
  7. Klaassen, C D

    1. You have access
      Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases.
      L Liu and C D Klaassen
      Molecular Pharmacology September 1996, 50 (3) 565-572;
  8. Knoll, B J

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  9. Kurose, K

    1. You have access
      Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1.
      M Tohkin, K Kurose and M Fukuhara
      Molecular Pharmacology September 1996, 50 (3) 556-564;

L

  1. Lau, S S

    1. You have access
      Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
      J K Jeong, J L Stevens, S S Lau and T J Monks
      Molecular Pharmacology September 1996, 50 (3) 592-598;
  2. Lee, H C

    1. You have access
      Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
      H Yu, J J Cai and H C Lee
      Molecular Pharmacology September 1996, 50 (3) 549-555;
  3. Lerner, M R

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;
  4. Levi, P E

    1. You have access
      Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver.
      D Y Ryu, P E Levi, P Fernandez-Salguero, F J Gonzalez and E Hodgson
      Molecular Pharmacology September 1996, 50 (3) 443-446;
  5. Lheureux, F

    1. You have access
      BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;
  6. Li, L Y

    1. You have access
      The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors.
      L Y Li and K J Chang
      Molecular Pharmacology September 1996, 50 (3) 599-602;
  7. Liliom, K

    1. You have access
      N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
      K Liliom, R Bittman, B Swords and G Tigyi
      Molecular Pharmacology September 1996, 50 (3) 616-623;
  8. Lindberg, R L

    1. You have access
      Role of heme in cytochrome P450 transcription and function in mice treated with lead acetate.
      R Jover, R L Lindberg and U A Meyer
      Molecular Pharmacology September 1996, 50 (3) 474-481;
  9. Ling, N

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  10. Liu, L

    1. You have access
      Ontogeny and hormonal basis of male-dominant rat hepatic sulfotransferases.
      L Liu and C D Klaassen
      Molecular Pharmacology September 1996, 50 (3) 565-572;
  11. Liu, X J

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  12. Liu, Z

    1. You have access
      BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;
  13. Lobaugh, L A

    1. You have access
      Constitutive activation of a phosphoinositidase C-linked G protein in murine fibroblasts decreases agonist-stimulated Ca2+ mobilization.
      L A Lobaugh, B Eisfelder, K Gibson, G L Johnson and J W Putney
      Molecular Pharmacology September 1996, 50 (3) 493-500;
  14. Lombardi, P

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;

M

  1. Macdonald, R L

    1. You have access
      Pharmacological properties of gamma-aminobutyric acidA receptors from acutely dissociated rat dentate granule cells.
      J Kapur and R L Macdonald
      Molecular Pharmacology September 1996, 50 (3) 458-466;
  2. Mason, R P

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  3. Matthes, H

    1. You have access
      Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
      H Matthes, E P Seward, B Kieffer and R A North
      Molecular Pharmacology September 1996, 50 (3) 447-450;
  4. McDevitt, P

    1. You have access
      Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
      A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson
      Molecular Pharmacology September 1996, 50 (3) 529-537;
  5. McEwan, I J

    1. You have access
      Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.
      J C Rowlands, I J McEwan and J A Gustafsson
      Molecular Pharmacology September 1996, 50 (3) 538-548;
  6. McNulty, D

    1. You have access
      Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
      A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson
      Molecular Pharmacology September 1996, 50 (3) 529-537;
  7. Meyer, U A

    1. You have access
      Role of heme in cytochrome P450 transcription and function in mice treated with lead acetate.
      R Jover, R L Lindberg and U A Meyer
      Molecular Pharmacology September 1996, 50 (3) 474-481;
  8. Millman, E E

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  9. Molinoff, P B

    1. You have access
      Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
      J Zhong, V K Gribkoff and P B Molinoff
      Molecular Pharmacology September 1996, 50 (3) 631-638;
  10. Monks, T J

    1. You have access
      Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
      J K Jeong, J L Stevens, S S Lau and T J Monks
      Molecular Pharmacology September 1996, 50 (3) 592-598;
  11. Moore, R H

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  12. Moran, J L

    1. You have access
      Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells.
      J L Moran, D Siegel, X M Sun and D Ross
      Molecular Pharmacology September 1996, 50 (3) 610-615;
  13. Morrison, K J

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;

N

  1. Nestler, E J

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;
  2. North, R A

    1. You have access
      Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
      H Matthes, E P Seward, B Kieffer and R A North
      Molecular Pharmacology September 1996, 50 (3) 447-450;
  3. Nouet, S

    1. You have access
      Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
      P Chidiac, S Nouet and M Bouvier
      Molecular Pharmacology September 1996, 50 (3) 662-669;

O

  1. Ordentlich, A

    1. You have access
      Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;

P

  1. Palmer, S F

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  2. Pouliot, J F

    1. You have access
      BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
      Z Liu, F Lheureux, J F Pouliot, A Heckel, U Bamberger and E Georges
      Molecular Pharmacology September 1996, 50 (3) 482-492;
  3. Pratesi, G

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  4. Putney, J W

    1. You have access
      Constitutive activation of a phosphoinositidase C-linked G protein in murine fibroblasts decreases agonist-stimulated Ca2+ mobilization.
      L A Lobaugh, B Eisfelder, K Gibson, G L Johnson and J W Putney
      Molecular Pharmacology September 1996, 50 (3) 493-500;

Q

  1. Quillan, J M

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;

R

  1. Ross, D

    1. You have access
      Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells.
      J L Moran, D Siegel, X M Sun and D Ross
      Molecular Pharmacology September 1996, 50 (3) 610-615;
  2. Rowlands, J C

    1. You have access
      Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.
      J C Rowlands, I J McEwan and J A Gustafsson
      Molecular Pharmacology September 1996, 50 (3) 538-548;
  3. Ryu, D Y

    1. You have access
      Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon-responsive receptor knock-out mouse liver.
      D Y Ryu, P E Levi, P Fernandez-Salguero, F J Gonzalez and E Hodgson
      Molecular Pharmacology September 1996, 50 (3) 443-446;

S

  1. Sadeghi, H

    1. You have access
      A fully active nonglycosylated V2 vasopressin receptor.
      G Innamorati, H Sadeghi and M Birnbaumer
      Molecular Pharmacology September 1996, 50 (3) 467-473;
  2. Salvatore, C

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  3. Schmidt, R R

    1. You have access
      Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;
  4. Seward, E P

    1. You have access
      Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
      H Matthes, E P Seward, B Kieffer and R A North
      Molecular Pharmacology September 1996, 50 (3) 447-450;
  5. Shafferman, A

    1. You have access
      Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;
  6. Shreeve, S M

    1. You have access
      Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
      N L Diehl, J C Kermode and S M Shreeve
      Molecular Pharmacology September 1996, 50 (3) 624-630;
  7. Siegel, D

    1. You have access
      Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells.
      J L Moran, D Siegel, X M Sun and D Ross
      Molecular Pharmacology September 1996, 50 (3) 610-615;
  8. Sikela, J

    1. You have access
      Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;
  9. Sivertsen, S

    1. You have access
      D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
      M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland
      Molecular Pharmacology September 1996, 50 (3) 501-505;
  10. Spiegel, S

    1. You have access
      Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity.
      A Berger, R Bittman, R R Schmidt and S Spiegel
      Molecular Pharmacology September 1996, 50 (3) 451-457;
  11. Stadel, J M

    1. You have access
      Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
      A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson
      Molecular Pharmacology September 1996, 50 (3) 529-537;
  12. Stefanovic, B

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  13. Stevens, J L

    1. You have access
      Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
      J K Jeong, J L Stevens, S S Lau and T J Monks
      Molecular Pharmacology September 1996, 50 (3) 592-598;
  14. Sun, X M

    1. You have access
      Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells.
      J L Moran, D Siegel, X M Sun and D Ross
      Molecular Pharmacology September 1996, 50 (3) 610-615;
  15. Supino, R

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
  16. Sutherland, R L

    1. You have access
      D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
      M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland
      Molecular Pharmacology September 1996, 50 (3) 501-505;
  17. Swords, B

    1. You have access
      N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
      K Liliom, R Bittman, B Swords and G Tigyi
      Molecular Pharmacology September 1996, 50 (3) 616-623;

T

  1. Tatro, J B

    1. You have access
      Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction.
      J D Alvaro, J B Tatro, J M Quillan, M Fogliano, M Eisenhard, M R Lerner, E J Nestler and R S Duman
      Molecular Pharmacology September 1996, 50 (3) 583-591;
  2. Thomas, D

    1. You have access
      Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;
  3. Thompson, S A

    1. You have access
      Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;
  4. Thurman, R G

    1. You have access
      Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat.
      Y Iimuro, B U Bradford, W Gao, M Kadiiska, R P Mason, B Stefanovic, D A Brenner and R G Thurman
      Molecular Pharmacology September 1996, 50 (3) 656-661;
  5. Tigyi, G

    1. You have access
      N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
      K Liliom, R Bittman, B Swords and G Tigyi
      Molecular Pharmacology September 1996, 50 (3) 616-623;
  6. Tohkin, M

    1. You have access
      Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1.
      M Tohkin, K Kurose and M Fukuhara
      Molecular Pharmacology September 1996, 50 (3) 556-564;
  7. Trial, J

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;
  8. True, C D

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  9. Tuvim, M

    1. You have access
      Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
      K J Morrison, R H Moore, N D Carsrud, J Trial, E E Millman, M Tuvim, R B Clark, R Barber, B F Dickey and B J Knoll
      Molecular Pharmacology September 1996, 50 (3) 692-699;

V

  1. Vale, W W

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  2. Van Rhee, A M

    1. You have access
      Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
      Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology September 1996, 50 (3) 512-521;
  3. Vaughn, J

    1. You have access
      125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
      D E Grigoriadis, X J Liu, J Vaughn, S F Palmer, C D True, W W Vale, N Ling and E B De Souza
      Molecular Pharmacology September 1996, 50 (3) 679-686;
  4. Velan, B

    1. You have access
      Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
      H Grosfeld, D Barak, A Ordentlich, B Velan and A Shafferman
      Molecular Pharmacology September 1996, 50 (3) 639-649;

W

  1. Wafford, K A

    1. You have access
      Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;
  2. Wang, X

    1. You have access
      Mercury binding site on Na+/K(+)-ATPase: a cysteine in the first transmembrane segment.
      X Wang and J D Horisberger
      Molecular Pharmacology September 1996, 50 (3) 687-691;
  3. Watts, C K

    1. You have access
      D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
      M L Handel, C K Watts, S Sivertsen, R O Day and R L Sutherland
      Molecular Pharmacology September 1996, 50 (3) 501-505;
  4. Wess, J

    1. You have access
      Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
      Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology September 1996, 50 (3) 512-521;
  5. Whiting, P J

    1. You have access
      Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;
  6. Wilcox, A S

    1. You have access
      Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit.
      K A Wafford, S A Thompson, D Thomas, J Sikela, A S Wilcox and P J Whiting
      Molecular Pharmacology September 1996, 50 (3) 670-678;
  7. Wong, A

    1. You have access
      Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
      A Wong, S M Hwang, P McDevitt, D McNulty, J M Stadel and K Johanson
      Molecular Pharmacology September 1996, 50 (3) 529-537;

Y

  1. Yehle, S

    1. You have access
      Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.
      Q Jiang, A M Van Rhee, J Kim, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology September 1996, 50 (3) 512-521;
  2. Yu, H

    1. You have access
      Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
      H Yu, J J Cai and H C Lee
      Molecular Pharmacology September 1996, 50 (3) 549-555;

Z

  1. Zhong, J

    1. You have access
      Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
      J Zhong, V K Gribkoff and P B Molinoff
      Molecular Pharmacology September 1996, 50 (3) 631-638;
  2. Zhu, D

    1. You have access
      Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
      D Zhu, M E Cardenas and J Heitman
      Molecular Pharmacology September 1996, 50 (3) 506-511;
  3. Zunino, F

    1. You have access
      Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
      F Animati, F Arcamone, M Bigioni, G Capranico, C Caserini, M De Cesare, P Lombardi, G Pratesi, C Salvatore, R Supino and F Zunino
      Molecular Pharmacology September 1996, 50 (3) 603-609;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 50, Issue 3
1 Sep 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics